Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst/Investor Meet24-08-2023
24-08-2023
Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Change in Directorate
Completion of term as Independent Directors viz. Mr. Sunil Varma, Dr. Saurabh Srivastava, Mr. Anoop Mahendra Singh and Mr. Harneet Singh Chandhoke.20-08-2023
Technical analysis of DLF, Zomato and Dr. Lal PathLabs. What the charts say?
We zoom in on the prospects of DLF, as also the prospects of two other stocks Zomato and Dr. Lal PathLabs19-08-2023
Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Intimation regarding dispatch of Notice of 29th Annual General Meeting18-08-2023
Dr. Lal PathLabs Ltd - 539524 - Business Responsibility and Sustainability Reporting (BRSR)
Business Responsibility and Sustainability Report for F Y 2022-2317-08-2023
Dr. Lal PathLabs Ltd - 539524 - Notice Convening 29Th Annual General Meeting
Intimation regarding Notice of 29th Annual General Meeting to be held on September 12, 202317-08-2023
Dr. Lal PathLabs Ltd - 539524 - Reg. 34 (1) Annual Report.
Pursuant to the provisions of Regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the Annual Report of the Company for the Financial Year 2022-23.17-08-2023
Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Advertisement regarding intimation about Annual General Meeting of the Company15-08-2023
Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation regarding Schedule of Investor Meet11-08-2023
Dr Lal PathLabs shares rise on Q1 results
Dr Lal PathLabs' revenue grew 7.76% to 541 crore in the June ended quarter09-08-2023